We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

1 hedge funds and large institutions have $11K invested in Kindred Biosciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $2K | Put options by funds: $1K

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 85

99% less funds holding

Funds holding: 87 → 1 (-86)

100% less capital invested

Capital invested by funds: $280M → $11K (-$280M)

Holders
1
Holders Change
-86
Holders Change %
-98.85%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
85
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
-$3.23M

Top Buyers

Rank Fund Capital Flow
1
CFO
CVA Family Office
Colorado
+$23K

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$55M
2
Millennium Management
Millennium Management
New York
-$25.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$17.3M
4
Fidelity International
Fidelity International
Bermuda
-$16.6M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$14.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFO
1
CVA Family Office
Colorado
$11K +$23K +2,500 New
PWAM
2
Park West Asset Management
California
– -$55M -6,000,002 Closed
MF
3
Magnetar Financial
Illinois
– -$31.5K -3,431,998 Closed
Millennium Management
4
Millennium Management
New York
– -$25.2M -2,751,857 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
– -$17.3M -1,890,913 Closed
Fidelity International
6
Fidelity International
Bermuda
– -$16.6M -1,810,000 Closed
Point72 Asset Management
7
Point72 Asset Management
Connecticut
– -$14.9M -1,620,476 Closed
Renaissance Technologies
8
Renaissance Technologies
New York
– -$12.1M -1,321,859 Closed
GIM
9
Granahan Investment Management
Massachusetts
– -$11.4M -1,243,842 Closed
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
– -$11.4M -1,242,474 Closed
Ameriprise
11
Ameriprise
Minnesota
– -$10.2M -1,109,851 Closed
GF
12
Gabelli Funds
New York
– -$7.78M -848,344 Closed
BlackRock
13
BlackRock
New York
– -$7.5M -817,300 Closed
PAMP
14
Polar Asset Management Partners
Ontario, Canada
– -$6.62M -722,191 Closed
Morgan Stanley
15
Morgan Stanley
New York
– -$6.47M -706,114 Closed
Allianz Asset Management
16
Allianz Asset Management
Germany
– -$6.15M -670,262 Closed
JP Morgan Chase
17
JP Morgan Chase
New York
– -$4.57M -498,252 Closed
SG Americas Securities
18
SG Americas Securities
New York
– -$4.43M -482,620 Closed
Balyasny Asset Management
19
Balyasny Asset Management
Illinois
– -$4.42M -482,563 Closed
GCL
20
Glazer Capital LLC
New York
– -$4.17M -454,164 Closed
E
21
Ergoteles
New York
– -$4.05M -441,884 Closed
Geode Capital Management
22
Geode Capital Management
Massachusetts
– -$4M -435,705 Closed
Wells Fargo
23
Wells Fargo
California
– -$3.92M -426,835 Closed
DA
24
DCF Advisers
Connecticut
– -$3.32M -362,315 Closed
SAM
25
Silverback Asset Management
North Carolina
– -$2.75M -300,000 Closed
1
2 3 4

KIN Hedge Fund Activity: Q3 2021 in Review

1 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2021, worth a combined $11K — down 100% from $280M a quarter earlier.

Sellers outnumbered buyers: 85 funds closed out of KIN and 1 opened new positions — a net loss of 84 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was CVA Family Office, opening a new position worth an estimated $23K. The largest seller was Park West Asset Management, exiting entirely with an estimated $55M sold.

  • 1 institutional investor held Kindred Biosciences, Inc. (KIN) as of Q3 2021, down from 87 in Q2 2021.
  • Funds reported $11K of Kindred Biosciences, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Kindred Biosciences, Inc. positions in Q3 2021 and 85 closed out, a net change of -84 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q3 2021 was CVA Family Office, an estimated $23K added.
  • The largest Kindred Biosciences, Inc. seller in Q3 2021 was Park West Asset Management, an estimated $55M sold.

Based on aggregated 13F filings for Q3 2021.